In response to sustained growth in sample volume, SCMM is in the process of increasing its MaterniT21 PLUS test capacity by completing the build out and initiating the validation of an additional location in North Carolina.
During 2012, SCMM established itself as the leader in the NIPT field with the good acceptance of MaterniT21 PLUS by the medical community," said Harry Hixson, Jr.
Fourth quarter 2012 revenues from the genetic analysis operating segment were essentially flat year-over-year, while revenues from the SCMM diagnostics services operating segment grew to $21.
2 million for the fourth quarter of 2011, resulting primarily from higher labor costs associated with the expansion of the SCMM sales force and marketing efforts.
SCMM accessioned 92,000 samples during 2012 as compared to 23,300 samples accessioned during the prior year.
Second, we initiated this LDT validation study to obtain extensive clinical data in support of faster adoption of an LDT by our CLIA-certified laboratory, SCMM.
SCMM is a Clinical Laboratory Improvement Act (CLIA)-certified clinical diagnostics laboratory based in Grand Rapids, Michigan.
Except for the historical information contained herein, the matters set forth in this press release, including statements regarding the collaboration between Obstretix and SCMM, Sequenom's SEQureDx Technology, including the potential applications, benefits and impact of such technology and the continuing development and commercialization of such technology, the LDT validation study and the RNA study, future opportunities for and benefits of noninvasive prenatal diagnostic tests, Sequenom's commitment to becoming a leader in noninvasive prenatal diagnostics, and Sequenom's ability to develop and commercialize diagnostic tests on multiple platforms, , are forward-looking statements within the meaning of the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995.
9 yr) underwent standard primary closure along with an SCMM flap (flap group).
The only difference between the two groups was the use of the SCMM flap (figure).
Albirmawy compared the use and nonuse of a SCMM collar flap to prevent pharyngocutaneous fistula in 65 patients who had undergone total laryngectomy.
In conclusion, our study demonstrated a dramatic decrease in the incidence of postlaryngectomy pharyngocutaneous fistula by addition of an SCMM flap to cover the pharyngeal defect at surgery.